Milbemycin A3

Milbemycin A3 (CAS No.: 51596-10-2) is a macrocyclic lactone derived from the fermentation of the soil bacterium Streptomyces hygroscopicus subsp. aureolacrimosus and belongs to a class of bioactive natural products widely investigated for antiparasitic applications. It exerts its biological effects primarily by potentiating glutamate- and γ-aminobutyric acid (GABA)-gated chloride channels, leading to increased chloride ion influx, disruption of neuronal signal transmission, and subsequent paralysis and death in susceptible invertebrates such as nematodes and mites. This mechanism underlies its established insecticidal, acaricidal, and nematocidal activities, with reported in vitro inhibitory effects against targets such as spider mites and Caenorhabditis elegans observed in the low micromolar range. As part of the milbemycin family, it is frequently studied alongside structurally related analogs to explore structure–activity relationships and optimize antiparasitic efficacy. In biomedical and agricultural research contexts, Milbemycin A3 is commonly utilized as a tool compound for investigating ion channel modulation, neurotoxic pathways in invertebrate models, and for screening novel antiparasitic agents, with experimental concentrations tailored to specific assay systems and organismal models.